Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment-Reference-Cited by-同舟云学术

Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment

Published:2016-11-30 Issue:4 Volume:14 Page:345-350
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Güneş Mehmet¹,Camkurt Mehmet Akif²,Bulut Mahmut¹,Demir Süleyman¹,İbiloğlu Aslıhan Okan¹,Kaya Mehmet Cemal¹,Atlı Abdullah¹,Kaplan İbrahim³,Sir Aytekin¹

Affiliation:

1. Department of Psychiatry, Faculty of Medicine, Dicle University, Diyarbakir, Turkey

2. Department of Biochemistry, Faculty of Medicine, Dicle University, Diyarbakir, Turkey

3. Department of Psychiatry, State Hospital of Afsin, Kahramanmaras, Turkey

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2016/014/cpn014-04-04.pdf

Reference32 articles.

1. Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison